US Stock MarketDetailed Quotes
COEP Coeptis Therapeutics
- 0.360
- -0.010-2.60%
Close May 3 16:00 ET
- 0.368
- +0.008+2.22%
Post 18:50 ET
12.99MMarket Cap-433P/E (TTM)
0.408High0.360Low316.09KVolume0.364Open0.370Pre Close119.78KTurnover1.56%Turnover RatioLossP/E (Static)36.09MShares2.19052wk High3.00P/B7.27MFloat Cap0.28552wk Low--Dividend TTM20.21MShs Float21.420Historical High--Div YieldTTM12.85%Amplitude0.285Historical Low0.378Avg Price1Lot Size
About Coeptis Therapeutics Company
Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company, which engages in developing innovative cell therapy platforms for cancer that can disrupt conventional treatment paradigms and improve patient outcomes. The firm's products include CD38-GEAR-NK, CD38-Diagnostic and GEAR-NK Product. The company was founded in 2017 and is headquartered in Wexford, PA.
Company Profile
SymbolCOEP
Company NameCoeptis Therapeutics
Listing DateDec 17, 2020
Founded2017
CEOMr. David Mehalick
MarketNASDAQ
Employees7
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address105 Bradford Road,Suite 420
CityWexford
ProvincePennsylvania
CountryUnited States of America
Zip Code15090
Phone1-724-934-6467
Websitehttp://www.coeptistx.com
Company Executives
- Name
- Position
- Salary
- David Mehalick
- Chairman of the Board, President and Chief Executive Officer
- 18.33K
- Dr. Colleen Delaney, M.D.
- Chief Scientific and Medical Officer
- 360.00K
- Brian Cogley
- Chief Financial Officer
- 208.00K
- Christine Sheehy
- Vice President, Compliance and Corporate Secretary
- 151.00K
- Daniel Yerace
- Director and Vice President of Operations
- 18.33K
- Christopher Calise
- Director
- 18.33K
- Christopher Cochran
- Independent Director
- 18.33K
- Dr. Tara Maria DeSilva
- Independent Director
- 18.33K
- Philippe Deschamps
- Independent Director
- 18.33K
- Dr. Gene Salkind, M.D.
- Independent Director
- 18.33K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg